Stick2PrEP Cisgender Women and Trans Individuals

Abroad (travel likely)Recruiting

Conditions

HIV Prevention · Pre-exposure Prophylaxis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Deborah Theodore, MD) · dat2132@cumc.columbia.edu · 212-305-2201

Study leads

Magdalena Sobieszczyk, MD, MPH
Principal Investigator
Columbia University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

HIV · Prophylaxis · Injectable

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

Predictors of Health Service Utilizations Among Key Population in Washington DC

Pre-exposure Prophylaxis · HIV · Health Behavior

Abroad (travel likely)Recruiting

Washington D.C., United States

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Mobile, United States

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

HIV · Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States